|
Del Carmen Asensio Lopez M, Lax A, Hernandez Vicente A, Saura Guillen E, Hernandez-Martinez A, Fernandez Del Palacio MJ, Bayes-Genis A, Pascual Figal DA. Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. Sci Rep. 2020 Oct 9;10(1):17266. doi: 10.1038/s41598-020-73065-5. PubMed PMID: 33037250; PubMed Central PMCID: PMC7547718.
AÑO: 2020; IF: 4.379
|
33037250
|
Revuelta-Lopez E, Lupon J, Lax A, Pascual-Figal DA, Bayes-Genis A. Differences in the Interleukin-1beta/Soluble ST2 Interplay Between Acute and Chronic Heart Failure. J Cardiovasc Transl Res. 2020 Oct;13(5):864-866. doi: 10.1007/s12265-020-09958-7. Epub 2020 Jan 22. PubMed PMID: 31970669.
AÑO: 2020; IF: 4.132
|
|
Asensio Lopez MDC, Lax A, Hernandez Vicente A, Saura Guillen E, Hernandez-Martinez A, Fernandez Del Palacio MJ, Bayes-Genis A, Pascual Figal DA. Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. Sci Rep. 2020 Aug 11;10(1):13553. doi: 10.1038/s41598-020-70454-8. Erratum In: Sci Rep. 2020 Oct 9;10(1):17266. PubMed PMID: 32782412; PubMed Central PMCID: PMC7419540.
AÑO: 2020; IF: 4.379
|
|
Pascual-Figal DA, Bayes-Genis A, Asensio-Lopez MC, Hernandez-Vicente A, Garrido-Bravo I, Pastor-Perez F, Diez J, Ibanez B, Lax A. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure. J Am Coll Cardiol. 2019 Mar 12;73(9):1016-1025. doi: 10.1016/j.jacc.2018.11.054. PubMed PMID: 30846095.
AÑO: 2019; IF: 20.589
|
|
Sanchez-Mas J, Saura-Guillen E, Asensio-Lopez MC, Soriano-Filiu A, Carmen Sanchez-Perez M, Hernandez-Martinez AM, Lax A, Pascual-Figal D. Temporal characterization of cardiac expression of glucose transporters SGLT and GLUT in an experimental model of myocardial infarction. Diabetes Metab. 2019 Apr;45(2):201-204. doi: 10.1016/j.diabet.2017.09.008. Epub 2017 Oct 31. No abstract available. PubMed PMID: 29097004.
AÑO: 2019; IF: 4.731
|